Template

Zeige index

Template CDA LabeledDrug 2005‑09‑07

Id2.16.840.1.113883.10.12.310
ref
ad1bbr-
Gültigkeit ab2005‑09‑07
Statusactive Versions-Label
NameCDALabeledDrugBezeichnungCDA LabeledDrug
Beschreibungen-US Template CDA LabeledDrug (prototype, directly derived from POCD_RM000040 MIF)
Klassifikation
Offen/GeschlossenOffen (auch andere als die definierten Elemente sind erlaubt)
Benutzt von / Benutzt
Benutzt von 4 Transactions und 162 Templates, Benutzt 0 Templates
Benutzt von als NameVersion
2.16.840.1.113883.3.1937.99.61.26.4.7Transaktiondraft en-US Base Document2016‑10‑08 19:37:05
2.16.840.1.113883.2.9.10.1.10.4.3Transaktiondraft (it-IT) Crea Act2018‑07‑20 17:01:17
2.16.756.5.30.1.127.77.2.4.2Transaktiondraft en-US CDA-CH - StructuredBody (2020)2017‑11‑10 09:35:28
2.16.756.5.30.1.127.77.2.4.4Transaktioncancelled en-US CDA-CH - StructuredBody Enhanced (2018)2018‑02‑12 17:54:58
1.2.40.0.34.6.0.11.3.139linkactive EXNDS Preis Arzneimittel (1.0.0+20210310)2020‑10‑06 15:47:15
1.2.208.184.2.10.9linkdraft CDA ClinicalDocument (with StructuredBody)2023‑07‑04 08:28:40
1.2.208.184.10.1.10linkcancelled DK ClinicalDocument (with StructuredBody)2021‑08‑30 14:09:05
1.2.208.184.10.1.13linkdraft DK Medcom ClinicalDocument (with StructuredBody) (1.5)2021‑08‑30 14:26:22
1.2.208.184.10.1.44linkdraft DK Medcom ClinicalDocument (with StructuredBody) (1.5)2023‑07‑04 13:52:36
1.2.208.184.10.15linkdraft PDC DK CDA Section2019‑12‑14 17:24:10
1.2.208.184.10.32linkdraft APD CDA Clinical Statement2020‑06‑21 16:54:06
1.2.208.184.10.33linkdraft APD CDA Observation2020‑06‑21 17:05:15
1.2.208.184.11.1.1linkcancelled DK CDA ClinicalDocument (with StructuredBody)2021‑08‑13 10:06:00
1.2.208.184.15.1.10.20.1linkdraft Health Concern Section2018‑11‑28 20:54:17
1.2.208.184.15.1.10.20.2linkdraft Goal Section2018‑11‑28 20:58:20
1.2.208.184.15.1.10.20.3linkdraft Interventions Section2018‑11‑28 21:00:20
1.2.208.184.15.1.10.20.4linkdraft Outcomes Section2018‑11‑28 21:01:23
1.2.208.184.16.1.10.20.1.20linkdraft PDC DK Language CDA Observation2019‑12‑22 11:41:45
1.2.208.184.16.1.10.20.1.21linkdraft PDC DK Temporary Address CDA Observation2019‑12‑22 11:43:31
1.2.208.184.16.1.10.20.1.22linkdraft PDC DK Dentist CDA Observation2019‑12‑22 11:45:33
1.2.208.184.16.1.10.20.1.23linkdraft PDC DK Custody CDA Observation2019‑12‑22 11:22:08
1.2.208.184.16.1.10.20.1.24linkdraft PDC DK Contact CDA Observation2019‑12‑22 11:46:44
1.2.208.184.16.1.10.20.1.25linkdraft PDC DK Relative CDA Observation2019‑12‑22 11:48:03
1.2.208.184.16.1.10.20.1.26linkdraft PDC DK Citizen CDA Observation2019‑12‑22 11:29:00
1.2.208.184.16.1.10.20.1.27linkdraft PDC DK Coverage CDA Observation2019‑12‑22 11:33:55
1.2.208.184.16.1.10.20.1.28linkdraft PDC DK Organ CDA Observation2019‑12‑22 11:35:31
1.2.208.184.16.1.10.20.1.29linkdraft PDC DK Treatment Will CDA Observation2019‑12‑22 11:38:15
1.2.208.184.16.1.10.20.1.30linkdraft PDC DK Living Will CDA Observation2019‑12‑22 11:39:56
1.2.276.0.76.3.1.85.200.77.10.2linkdraft Diagnose2016‑01‑29 12:27:26
1.2.276.0.76.3.1.85.200.77.10.3linkdraft Therapie2016‑01‑29 12:28:19
1.2.276.0.76.3.1.85.200.77.10.4linkdraft Wundbeurteilung2016‑01‑29 12:33:12
1.2.276.0.76.3.1.85.200.77.10.7linkdraft psychosoziale Faktoren2016‑02‑04 15:14:55
1.2.276.0.76.3.1.85.200.77.10.8linkdraft individuelle Risikofaktoren2016‑02‑04 15:24:45
1.2.276.0.76.3.1.85.200.77.10.9linkdraft Risikoasssessment2016‑02‑04 15:28:02
1.2.276.0.76.3.1.85.200.77.10.10linkdraft HygieneAssessment2016‑02‑04 15:30:47
1.2.276.0.76.3.1.85.200.77.10.11linkdraft Hautassessment2016‑02‑04 15:33:52
1.2.276.0.76.3.1.85.200.77.10.12linkdraft Details über geheilte Wunden2016‑02‑04 15:37:09
1.2.276.0.76.3.1.85.200.77.10.13linkdraft gesundheitsrelevantes Patientenverhalten2016‑02‑04 15:45:40
1.2.276.0.76.3.1.85.200.77.10.14linkdraft körperliche Beeinträchtigungen2016‑02‑04 15:48:19
1.2.276.0.76.3.1.85.200.77.10.15linkdraft psychosoziale Beeinträchtigungen2016‑02‑04 15:51:13
1.2.276.0.76.3.1.85.200.77.10.17linkdraft relevante med. Daten2016‑02‑04 16:07:34
1.2.276.0.76.3.1.85.200.77.10.18linkdraft Behandlungsziele2016‑02‑04 16:17:24
1.2.276.0.76.3.1.85.200.77.10.19linkdraft Behandlungsplan2016‑02‑04 16:22:01
1.2.276.0.76.3.1.85.200.77.10.20linkdraft benötigte Ausrüstung2016‑02‑04 16:27:22
1.2.276.0.76.3.1.85.200.77.10.21linkdraft Heilungs- und Therapieverlauf2016‑02‑04 16:32:28
1.2.276.0.76.3.1.85.200.77.10.22linkdraft Schmerzmanagement2016‑02‑04 16:36:00
1.2.276.0.76.3.1.85.200.77.10.23linkdraft Hygienemaßnahmen2016‑02‑04 16:40:10
1.2.276.0.76.3.1.85.200.77.10.24linkdraft Wundrandschutz2016‑02‑04 16:43:46
1.2.276.0.76.3.1.85.200.77.10.25linkdraft Kausaltherapie2016‑02‑04 16:46:11
1.2.276.0.76.3.1.85.200.77.10.26linkdraft Patientenedukation2016‑02‑04 16:49:29
1.2.276.0.76.3.1.85.200.77.10.27linkdraft bisherige Ergebnisse2016‑02‑04 16:54:50
1.2.276.0.76.10.4301linkdraft Medikation Abgabe Entry (16)2019‑03‑18 16:17:28
1.3.6.1.4.1.19376.1.3.1.6linkdraft IHE Laboratory Observation (LAB TF-3, Revision 6.0 - Final Text, July 14, 2015)2016‑06‑24 13:58:31
1.3.6.1.4.1.19376.1.3.3.2.2linkdraft Laboratory Report Item Section (LAB TF-3, Revision 6.0 - Final Text, July 14, 2015)2016‑06‑24 12:44:54
1.3.6.1.4.1.19376.1.3.10.4.2linkdraft UICC/AJCC TNM Staging and Grading Observation (2.0)2014‑05‑13 15:45:13
1.3.6.1.4.1.19376.1.3.10.4.4linkcancelled CDA Supply Container APSR2 (1.0)2016‑07‑29
1.3.6.1.4.1.19376.1.3.10.4.4linkcancelled Assessment Scales for Scoring Systems APSR2 (1.9)2016‑10‑06 12:36:29
1.3.6.1.4.1.19376.1.3.10.9.33linkdraft TNM Serum tumor markers (2.0)2015‑11‑06 14:28:44
1.3.6.1.4.1.19376.1.8.1.3.6linkdraft Problem Organizer (2.0)2015‑08‑13 10:24:55
1.3.6.1.4.1.19376.1.8.1.4.9linkdraft AP Observation Entry (2.0)2014‑05‑14 17:09:54
2.16.756.5.30.1.1.10.1.9linkactive CDA-CH v2.1 - structuredBody (2020)2019‑10‑17 15:22:41
2.16.756.5.30.1.1.10.1.14linkactive CDA-CH v2.0 - structuredBody enhanced (2018)2018‑04‑18
2.16.840.1.113883.2.6.60.2.10.3001linkdraft NFD Section Allergien, Unverträglichkeiten2014‑06‑29 13:35:11
2.16.840.1.113883.2.6.60.2.10.3005linkdraft NFD Section Schwangerschaft2014‑07‑07 14:19:33
2.16.840.1.113883.2.6.60.2.10.3006linkdraft NFD Section Risiken Ressourcen2014‑07‑07 14:32:47
2.16.840.1.113883.2.6.60.2.10.4004linkretired NFD Entry Problem2014‑07‑02 15:11:28
2.16.840.1.113883.2.6.60.2.10.4005linkdraft NFD Entry Medikation Verordnung2014‑07‑02 14:54:43
2.16.840.1.113883.2.6.60.3.10.1linkretired CDA SubstanceAdministration2016‑04‑22 10:50:09
2.16.840.1.113883.2.6.60.6.10.45linkdraft Elston-Ellis-Grading2016‑05‑24 21:55:39
2.16.840.1.113883.2.9.10.1.10.3linkdraft Act Esenzione2018‑05‑21 15:56:46
2.16.840.1.113883.2.9.77.1.10.900238linkdraft CDA Observation2016‑05‑28 22:16:29
2.16.840.1.113883.2.51.10.38linkcancelled XeH Care Provision Act2021‑10‑18 16:17:01
2.16.840.1.113883.3.51.60.2.0linkdraft BC CDA Clinical Document Header2016‑04‑03 18:54:58
2.16.840.1.113883.3.51.60.3.3linkdraft BC CDA StructuredBody2016‑04‑04 16:51:10
2.16.840.1.113883.3.1818.10.1.2.1linkrejected BC CDA ClinicalDocumentGenericEpisodic2016‑11‑28 15:06:29
2.16.840.1.113883.3.1818.10.1.3.1linkrejected BC CDA ClinicalDocumentPatientTransfer2017‑03‑30 10:51:43
2.16.840.1.113883.3.1818.10.3.3linkdraft BC Allergy Intolerance Observation Act2017‑04‑02 06:50:15
2.16.840.1.113883.3.1818.10.3.3linkdraft BC Allergy Intolerance Observation Act2017‑04‑02 08:00:43
2.16.840.1.113883.3.1818.10.3.3linkdraft BC Allergy Intolerance Observation Act2017‑04‑02 08:08:32
2.16.840.1.113883.3.1818.10.3.9linkdraft BC Encounter Event2017‑04‑02 22:14:30
2.16.840.1.113883.3.1818.10.4.7linkdraft BC Medication Dispense Event2017‑04‑01 05:18:24
2.16.840.1.113883.3.1818.10.4.20linkdraft BC Medication Prescription Event2017‑04‑01 06:19:37
2.16.840.1.113883.3.1818.10.4.24linkdraft BC Reason Observation2017‑04‑01 05:57:31
2.16.840.1.113883.3.1818.10.4.30linkdraft BC Severity Observation2017‑04‑01 22:54:28
2.16.840.1.113883.3.1818.10.4.36linkdraft BC Medication Administration2017‑04‑01 04:23:21
2.16.840.1.113883.3.1818.10.4.37linkdraft BC Order Indicator2017‑04‑01 05:39:26
2.16.840.1.113883.3.1818.10.4.38linkdraft BC Record ID Link2017‑04‑01 05:48:33
2.16.840.1.113883.3.1937.99.61.5.10.900216linkdraft CDA Observation2013‑12‑04 10:55:24
2.16.840.1.113883.3.1937.99.61.5.10.900239linkdraft eLab_Specimen Received_2014‑01‑14 14:12:16
2.16.840.1.113883.3.1937.99.61.5.10.900240linkdraft eLab_Specimen Received_2014‑01‑14 14:12:39
2.16.840.1.113883.3.1937.99.61.5.10.900241linkdraft eLab_Specimen Received_2014‑01‑14 14:13:27
2.16.840.1.113883.3.1937.99.61.5.10.900242linkdraft eLab_Specimen Received_2014‑01‑14 14:13:28
2.16.840.1.113883.3.1937.99.61.5.10.900243linkdraft eLab_Specimen Received_2014‑01‑14 14:13:28
2.16.840.1.113883.3.1937.99.61.5.10.900244linkdraft eLab_Specimen Received_2014‑01‑14 14:13:29
2.16.840.1.113883.3.1937.99.61.5.10.900245linkdraft eLab_Specimen Received_2014‑01‑14 14:13:29
2.16.840.1.113883.3.1937.99.61.5.10.900246linkdraft eLab_Specimen Received_2014‑01‑14 14:13:29
2.16.840.1.113883.3.1937.99.61.5.10.900247linkdraft eLab_Specimen Received_2014‑01‑14 14:13:30
2.16.840.1.113883.3.1937.99.61.5.10.900265linkdraft CDA Organizer2014‑01‑14 14:17:08
2.16.840.1.113883.3.1937.99.61.5.10.900276linkdraft TNM Observation2014‑05‑13 15:45:13
2.16.840.1.113883.3.1937.99.61.5.10.900280linkdraft APSR2 AP Observation Entry2014‑05‑14 17:09:54
2.16.840.1.113883.3.1937.99.61.5.10.900290linkdraft ADT-Tod2014‑12‑02 09:05:37
2.16.840.1.113883.3.1937.99.61.5.10.900293linkdraft ADT Tod2014‑12‑02 11:02:38
2.16.840.1.113883.3.1937.99.61.5.10.900296linkdraft TNM M-Observation2014‑12‑02 16:32:30
2.16.840.1.113883.3.1937.99.61.5.10.900304linkdraft APSR2 Specimen Organizer2014‑12‑22 17:58:40
2.16.840.1.113883.3.1937.99.61.5.10.900311linkdraft CDA SubstanceAdministration2018‑08‑02 12:16:53
2.16.840.1.113883.3.1937.99.61.5.10.900312linkdraft CDA SubstanceAdministration2018‑08‑02 12:18:33
2.16.840.1.113883.3.1937.99.61.19.10.24linkdraft CDA Observation12017‑08‑10 15:15:49
2.16.840.1.113883.3.1937.99.61.19.10.71linkdraft Ambulanzbefund2019‑05‑10 08:58:00
2.16.840.1.113883.3.1937.99.61.19.10.78linkactive TEST_AKL_Ambulanzbefund (2020)2020‑02‑05 15:44:24
2.16.840.1.113883.3.1937.99.61.19.10.78linkdraft TEST_AKL_Ambulanzbefund (2020.1)2020‑11‑25 10:42:33
2.16.840.1.113883.3.1937.99.61.21.10.75linkdraft Radiology Comparison Study - Observation2020‑08‑11 20:29:30
2.16.840.1.113883.3.1937.99.61.27.10.3linkdraft tsc_test_CDASection2016‑05‑27 11:53:53
2.16.840.1.113883.3.1937.99.61.27.10.4linkdraft Laboratory Specialty Text and Entry (LAB TF-3, Revision 6.0 - Final Text, July 14, 2015)2016‑06‑24 12:40:20
2.16.840.1.113883.3.1937.99.61.27.10.11linkdraft CDA Observation2018‑11‑13 14:00:31
2.16.840.1.113883.3.1937.99.61.27.10.12linkdraft JBl_CDA Observation (JBL-V1)2018‑11‑13 14:14:08
2.16.840.1.113883.3.1937.99.61.27.10.13linkdraft NewTemplate (V0)2018‑11‑13 14:14:16
2.16.840.1.113883.3.1937.99.61.27.10.14linkdraft JBl_CDA Observation (JBL-V1)2018‑11‑13 14:14:49
2.16.840.1.113883.3.1937.99.61.27.10.15linkdraft PGRNewTemplateTest (V0)2018‑11‑13 14:17:21
2.16.840.1.113883.3.1937.99.61.27.10.16linkdraft NewTemplate (V0)2018‑11‑13 14:17:38
2.16.840.1.113883.3.1937.99.61.27.10.17linkdraft CDA ClinicalDocument (with StructuredBody)2019‑08‑22 09:46:40
2.16.840.1.113883.3.1937.99.61.27.10.18linkdraft CDA ClinicalDocument (with StructuredBody)2019‑08‑22 09:46:48
2.16.840.1.113883.3.1937.99.61.27.10.19linkdraft FLM_SupplyOneRelationShipSubstanceAdministration (2019)2019‑08‑29 14:54:39
2.16.840.1.113883.3.1937.99.61.27.10.20linkdraft FLM_SubstanceAdministration2019‑08‑29 15:03:30
2.16.840.1.113883.3.1937.99.61.27.10.21linkdraft FLM_Supply2019‑08‑29 15:51:42
2.16.840.1.113883.3.1937.99.61.27.10.22linkdraft FLM_SubstanceAdministration22019‑09‑01 21:32:53
2.16.840.1.113883.3.1937.99.61.27.10.23linkdraft FLM_SupplyTwoRelationShipToSubstanceAdministration2019‑09‑01 21:33:57
2.16.840.1.113883.3.1937.99.61.28.10.4linkdraft CDA Nivel 1 (1)2017‑04‑22 23:33:51
2.16.840.1.113883.3.1937.99.61.30.10.64linkdraft Prescrizione specialistica (with StructuredBody) (1.0)2022‑06‑13 15:50:01
2.16.840.1.113883.3.1937.99.61.30.10.65linkdraft Prescrizione farmaceutica (with StructuredBody) (1.0)2022‑06‑13 17:14:33
2.16.840.1.113883.3.1937.99.61.31.10.1.2linkdraft My Section2014‑02‑08 16:16:07
2.16.840.1.113883.3.1937.99.61.45.10.5linkrejected CDA Section t2018‑04‑16 11:44:27
2.16.840.1.113883.3.1937.99.61.45.10.6linkrejected CDA Observation t2018‑04‑16 12:13:51
2.16.840.1.113883.3.1937.99.61.45.10.17linkcancelled CDA Adipositas Studie2018‑04‑24 10:41:37
2.16.840.1.113883.3.1937.99.61.45.10.37linkdraft Dok3 Sonstiges2018‑05‑02 17:52:41
2.16.840.1.113883.3.1937.99.61.45.10.39linkdraft Dok3 kleines Blutbild ?2018‑05‑02 17:58:11
2.16.840.1.113883.3.1937.99.61.45.10.50linkdraft ASIC weitere Vitaldaten2018‑05‑08 16:29:04
2.16.840.1.113883.3.1937.99.61.45.10.62linkdraft CDA Observation2018‑08‑28 13:22:11
2.16.840.1.113883.3.1937.777.17.10.7linkrejected BC Dispense Request (First Fill)2017‑03‑30 05:29:06
2.16.840.1.113883.3.1937.777.17.10.47linkrejected BC CDA Organizer2017‑04‑02 19:50:56
2.16.840.1.113883.3.1937.777.17.10.48linkrejected BC Clinically Measured Observations Organizer2017‑04‑02 19:58:41
2.16.840.1.113883.3.1937.777.17.10.50linkdraft BC CDA Organizer2017‑04‑02 20:15:06
2.16.840.1.113883.3.1937.777.21.10.6linkdraft CDA Observation2018‑07‑30 14:20:18
2.16.840.1.113883.3.1937.777.24.10.22linkdraft Omics2019‑02‑01 16:40:46
2.16.840.1.113883.3.1937.777.24.10.51linkdraft CDA Procedure B2019‑04‑01 15:54:18
2.16.840.1.113883.3.1937.777.26.10.1linkdraft Konsilanfrage2018‑07‑20 11:22:22
2.16.840.1.113883.3.1937.777.29.10.1linkdraft CDA ClinicalDocument (with StructuredBody)2019‑05‑02 16:51:55
2.16.840.1.113883.3.1937.777.60.10.3linkdraft DK Resume Section2021‑08‑09 13:15:46
2.16.840.1.113883.3.1937.777.78.10.8linkcancelled CDA Observation2024‑01‑26 11:33:16
2.16.840.1.113883.10.12.2linkactive CDA ClinicalDocument (with StructuredBody)2005‑09‑07
2.16.840.1.113883.10.12.201linkactive CDA Section2005‑09‑07
2.16.840.1.113883.10.12.202linkactive CDA StructuredBody2005‑09‑07
2.16.840.1.113883.10.12.300linkactive CDA Clinical Statement2005‑09‑07
2.16.840.1.113883.10.12.301linkactive CDA Act2005‑09‑07
2.16.840.1.113883.10.12.302linkactive CDA Encounter2005‑09‑07
2.16.840.1.113883.10.12.303linkactive CDA Observation2005‑09‑07
2.16.840.1.113883.10.12.304linkactive CDA ObservationMedia2005‑09‑07
2.16.840.1.113883.10.12.305linkactive CDA Organizer2005‑09‑07
2.16.840.1.113883.10.12.306linkactive CDA Procedure2005‑09‑07
2.16.840.1.113883.10.12.307linkactive CDA RegionOfInterest2005‑09‑07
2.16.840.1.113883.10.12.308linkactive CDA SubstanceAdministration2005‑09‑07
2.16.840.1.113883.10.12.309linkactive CDA Supply2005‑09‑07
2.16.840.1.113883.10.12.312Inklusionactive CDA ManufacturedProduct2005‑09‑07
2.16.840.1.113883.10.21.4.2linkpending UV Dispense Request (R1-STU2-ballot)2016‑05‑01
2.16.840.1.113883.10.21.4.15linkpending UV Medication Dispense (STU1)2019‑02‑17
2.999.1.1linkdraft tsc_test1_Obs1 (derived from CDA Observation)2016‑07‑01 16:24:10
2.999.2.1linkdraft tsc_test1_Obs2 (derived from tsc_test1_Obs1)2016‑07‑01 16:44:35
ItemDTKardKonfBeschreibungLabel
hl7:manufacturedLabeledDrug
CDALdotsDrug
@classCode
cs0 … 1FMMAT
@determinerCode
cs0 … 1FKIND
hl7:code
CE0 … 1CDALdotsDrug
 CONF
muss aus der Konzeptdomäne "DrugEntity" gewählt werden
hl7:name
EN0 … 1CDALdotsDrug